Atlas Trials

Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer

Clinical trial NCT03846128 · TERMINATED

Trial details

NCT number
NCT03846128
Sponsor
University Hospital, Rouen
Status
TERMINATED
Study type
OBSERVATIONAL
Metastatic Kidney Cancer
Start date
2019-06-03
Primary completion
2021-10-08
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.